Positive and negative influence of the matrix architecture on antitumor immune surveillance
- PMID: 23649148
- PMCID: PMC11113382
- DOI: 10.1007/s00018-013-1339-8
Positive and negative influence of the matrix architecture on antitumor immune surveillance
Abstract
The migration of T cells and access to tumor antigens is of utmost importance for the induction of protective anti-tumor immunity. Once having entered a malignant site, T cells encounter a complex environment composed of non-tumor cells along with the extracellular matrix (ECM). It is now well accepted that a deregulated ECM favors tumor progression and metastasis. Recent progress in imaging technologies has also highlighted the impact of the matrix architecture found in solid tumor on immune cells and especially T cells. In this review, we argue that the ability of T cells to mount an antitumor response is dependent on the matrix structure, more precisely on the balance between pro-migratory reticular fiber networks and unfavorable migration zones composed of dense and aligned ECM structures. Thus, the matrix architecture, that has long been considered to merely provide the structural framework of connective tissues, can play a key role in facilitating or suppressing the antitumor immune surveillance. A new challenge in cancer therapy will be to develop approaches aimed at altering the architecture of the tumor stroma, rendering it more permissive to antitumor T cells.
Figures




Similar articles
-
Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.Front Immunol. 2024 Apr 16;15:1340702. doi: 10.3389/fimmu.2024.1340702. eCollection 2024. Front Immunol. 2024. PMID: 38690275 Free PMC article. Review.
-
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.J Clin Invest. 2012 Mar;122(3):899-910. doi: 10.1172/JCI45817. Epub 2012 Feb 1. J Clin Invest. 2012. PMID: 22293174 Free PMC article.
-
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.Front Immunol. 2021 May 27;12:656364. doi: 10.3389/fimmu.2021.656364. eCollection 2021. Front Immunol. 2021. PMID: 34122412 Free PMC article. Review.
-
Proinvasive extracellular matrix remodeling for tumor progression.Arch Pharm Res. 2019 Jan;42(1):40-47. doi: 10.1007/s12272-018-1097-0. Epub 2018 Dec 4. Arch Pharm Res. 2019. PMID: 30515725 Review.
-
Obstacles to T cell migration in the tumor microenvironment.Comp Immunol Microbiol Infect Dis. 2019 Apr;63:22-30. doi: 10.1016/j.cimid.2018.12.006. Epub 2018 Dec 27. Comp Immunol Microbiol Infect Dis. 2019. PMID: 30961814
Cited by
-
Is adaptive therapy natural?PLoS Biol. 2018 Oct 2;16(10):e2007066. doi: 10.1371/journal.pbio.2007066. eCollection 2018 Oct. PLoS Biol. 2018. PMID: 30278037 Free PMC article.
-
Advances and Innovations of 3D Bioprinting Skin.Biomolecules. 2022 Dec 27;13(1):55. doi: 10.3390/biom13010055. Biomolecules. 2022. PMID: 36671440 Free PMC article. Review.
-
Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.Exp Ther Med. 2017 Oct;14(4):3399-3406. doi: 10.3892/etm.2017.4989. Epub 2017 Aug 22. Exp Ther Med. 2017. PMID: 29042925 Free PMC article.
-
Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment.J Dent Sci. 2021 Mar;16(2):661-667. doi: 10.1016/j.jds.2020.09.017. Epub 2020 Oct 16. J Dent Sci. 2021. PMID: 33854716 Free PMC article.
-
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.World J Gastroenterol. 2020 Jan 14;26(2):134-153. doi: 10.3748/wjg.v26.i2.134. World J Gastroenterol. 2020. PMID: 31969776 Free PMC article.
References
-
- Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2009;29(8):1093–1102. - PubMed
-
- Fisher DT, Chen Q, Appenheimer MM, Skitzki J, Wang WC, Odunsi K, Evans SS. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol Invest. 2006;35(3–4):251–277. - PubMed
-
- Wang SF, Fouquet S, Chapon M, Salmon H, Regnier F, Labroquere K, Badoual C, Damotte D, Validire P, Maubec E, Delongchamps NB, Cazes A, Gibault L, Garcette M, Dieu-Nosjean MC, Zerbib M, Avril MF, Prevost-Blondel A, Randriamampita C, Trautmann A, Bercovici N. Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors. PLoS One. 2011;6(3):e17621. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources